Amedisys Reports Second Quarter 2019 Financial Results and Updates 2019 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Amedisys (AMED) Tops Q2 EPS by 3c
July 31, 2019 4:22 PM EDTAmedisys (NASDAQ: AMED) reported Q2 EPS of $1.02, $0.03 better than the analyst estimate of $0.99. Revenue for the quarter came in at $492.98 million versus the consensus estimate of $489.38 million.
Paul B. Kusserow, President and Chief Executive Officer stated, I am very proud of our... More



